IRTC News and Press, iRhythm Technologies Inc. From 08/06/22

iRhythm Technologies, Inc. (IRTC) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President and Chief Executive Officer Doug Devine - Chief Operating Office...

Image source: The Motley Fool. iRhythm Technologies, Inc. Common Stock (NASDAQ: IRTC) Q2 2022 Earnings Call Aug 04, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: iRhythm Technologies, Inc. Common Stock (IRTC) Q2 2...

SAN FRANCISCO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended June 30, 2022. Second Quarter 2...

SAN FRANCISCO, July 28, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the company will be participating in the upcoming Canaccord Genuity 42nd Annual Growth St...

iRhythm Technologies ( NASDAQ: IRTC ) said Monday it appointed Brice Bobzien as CFO on Aug. 8. Bobzien most recently served as SVP of finance & investor relations at Dexcom. For further details see: iRhythm Technologies hires Brice Bobzien as CFO

SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced the appointment of two seasoned executives to its leadership team. Brice Bobzien will joi...

iRhythm Technologies ( NASDAQ: IRTC ) said on Friday it had received U.S. Food and Drug Administration clearance for its ECG Utilization Software ZEUS System for the Zio Watch. The ZEUS System combines algorithms with cardiac arrhythmia service. iRhythm plans to l...

SAN FRANCISCO, July 22, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced it received FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System f...

iRhythm Technologies ( NASDAQ: IRTC ) announced that Dave Vort, Chief Commercial Officer, has resigned effective July 25, 2022; he will continue to serve as  a strategic advisor and actively engage with the company's leadership team through Mar.31, 2023. Cha...

SAN FRANCISCO, July 18, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Dave Vort, the Company’s Chief Commercial Officer, has resigned effective Jul...